![Frank Condella](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Frank Condella
Director/Board Member at
Palladio Biosciences, Inc.
Net worth: 146 469 $ as of 30/08/2026
Profile
Frank C.
Condella is currently an Independent Director at Palladio Biosciences, Inc. Formerly, Mr. Condella was President & Chief Executive Officer at Alpharma Specialty Pharma LLC from 2000 to 2001 and at FH Faulding & Co. Ltd. during the same period.
Served as Chief Executive Officer at Faulding Pharmaceuticals Plc.
Held the position of Chairman at Mayne Pharma Group Ltd. from 2021 to 2026.
Was Non-Executive Vice Chairman at Vectura Group Ltd. from 2016 to 2018.
Chaired The Polycystic Kidney Disease Research Foundation.
Served as Non-Executive Director at Catalent JNP, Inc. from 2016 to 2017.
Was President-Europe & Managing Director-UK at IVAX LLC from 2002 to 2006.
Held Non-Executive Director roles at SkyePharma Plc (2009-2010), Fulcrum Pharma Plc, Prosonix Ltd., and was an Independent Director at Fertin Pharma A. Served as Vice President-Specialty Care Products at Roche Holding AG and Hoffmann-La Roche, Inc. Education includes undergraduate and MBAistration degrees from Northeastern University and an MBAistration from D'Amore-Mckim School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 29/06/2025 | 65,929 ( 0.08% ) | 146 469 $ | 30/08/2026 |
Frank Condella active positions
| Companies | Position | Start |
|---|---|---|
Palladio Biosciences, Inc.
 Palladio Biosciences, Inc. BiotechnologyHealth Technology Develops transformative medicines for orphan diseases | Director/Board Member | - |
Former positions of Frank Condella
| Companies | Position | End |
|---|---|---|
| MAYNE PHARMA GROUP LIMITED | Chairman | 13/01/2026 |
| VECTURA GROUP | Director/Board Member | 30/10/2018 |
| JUNIPER PHARMACEUTICALS INC | Chief Executive Officer | 31/07/2016 |
IVAX LLC
 IVAX LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures & markets branded and generic pharmaceuticals | Corporate Officer/Principal | - |
Alpharma Specialty Pharma LLC
 Alpharma Specialty Pharma LLC Medical DistributorsDistribution Services Distributes multi-source injectable pharmaceutical drugs | President | 30/09/2001 |
Training of Frank Condella
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
64
1st degree connections
17
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 17 |
|---|---|
Catalent JNP, Inc.
 Catalent JNP, Inc. Miscellaneous Commercial ServicesCommercial Services Specializes in research and development of drugs & therapeutics | Commercial Services |
IVAX LLC
IVAX LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures & markets branded and generic pharmaceuticals | Health Technology |
Roche Holding AG
 Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
SkyePharma Plc
 SkyePharma Plc Pharmaceuticals: OtherHealth Technology Manufactures and develops oral and inhalation pharmaceutical products | Health Technology |
Alpharma Specialty Pharma LLC
Alpharma Specialty Pharma LLC Medical DistributorsDistribution Services Distributes multi-source injectable pharmaceutical drugs | Distribution Services |
Vectura Group Ltd.
 Vectura Group Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures inhalation drugs and medical devices | Health Technology |
Fulcrum Pharma Plc
 Fulcrum Pharma Plc Pharmaceuticals: OtherHealth Technology Provides strategic drug development and regulatory service to the pharmaceutical and biotechnology industries | Health Technology |
FH Faulding & Co. Ltd.
 FH Faulding & Co. Ltd. Pharmaceuticals: MajorHealth Technology Produces and wholesales pharmaceutical, household and allied products | Health Technology |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Health Technology |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fertin Pharma A/S
 Fertin Pharma A/S Food: Specialty/CandyConsumer Non-Durables Develops and manufactures medical chewing gum products | Consumer Non-Durables |
Prosonix Ltd.
 Prosonix Ltd. Pharmaceuticals: MajorHealth Technology Develops a portfolio of inhaled respiratory medicines | Health Technology |
The Polycystic Kidney Disease Research Foundation
 The Polycystic Kidney Disease Research Foundation Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit healthcare organization that focused on polycystic kidney diseases | Commercial Services |
D'Amore-Mckim School of Business
 D'Amore-Mckim School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mayne Pharma Group Ltd.
 Mayne Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company, which develops and manufactures proprietary and generic products | Health Technology |
Faulding Pharmaceuticals Plc | |
Palladio Biosciences, Inc.
Palladio Biosciences, Inc. BiotechnologyHealth Technology Develops transformative medicines for orphan diseases | Health Technology |
- Stock Market
- Insiders
- Frank Condella
